President Trump’s State of the Union on Tuesday, February 24, 2026 made big healthcare claims. Some of it matters. Some of it is messaging. If you are shopping coverage in Florida, the practical move is to focus on what changes your monthly premium, deductible risk, and drug access right now.
What He Focused On
- Criticism of the ACA structure and insurer subsidies.
- A push for stronger healthcare price transparency.
- Prescription-drug pricing claims tied to a Most-Favored-Nation framework and TrumpRx.
- A call for Congress to codify parts of his drug-pricing approach.
What About HSAs?
Here is the key point: there was no detailed HSA expansion framework laid out in the speech text. No direct, concrete HSA benefit redesign was announced in that address itself.
If HSA policy becomes a serious federal focus later, we need actual bill language or finalized federal rules before anyone should make long-term plan decisions around it.
My Practical Take for Florida Households
- Short term: Nothing in that speech changes your immediate enrollment math by itself.
- For ACA shoppers: Your real decision remains subsidy eligibility, provider network fit, formulary fit, deductible exposure, and MOOP.
- For HSA-minded shoppers: HSAs still hinge on whether your plan is HSA-qualified under existing rules, not political talking points.
- For self-employed families: Keep documentation clean, estimate income accurately, and choose a plan you can actually use all year.
Bottom Line
I am all for lower costs and better transparency. But until policy details are enacted and operational, your best move is boring and disciplined: pick a medically usable plan, protect downside risk, and avoid hype-driven decisions.
Want a no-BS plan review based on your real numbers?
We can compare your options by network, prescriptions, deductible risk, and total annual exposure so you can make a clean decision.
Request Structured Plan ReviewSource note: This column references remarks from the February 24, 2026 State of the Union transcript. This post is opinion commentary and not tax or legal advice.